1.Chin, J. Control of Communicable Disease Manual, 17th edn. American Public Health Association, 2000.
2.Dubey, JP. Toxoplasma gondii. In: Baron, S, ed. Medical Microbiology, 4th edn. Gavelston, TX: University of Texas Medical Branch at Galveston, 1996.
3.Benenson, MW, et al. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. New England Journal of Medicine 1982; 307: 666–669.
4.Nissapatorn, V, et al. Toxoplasmosis: prevalence and risk factors. Journal of Obstetrics and Gynaecology 2003; 23: 618–624.
5.Jones, JL, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. American Journal of Epidemiology 2001; 154: 357–365.
6.Allain, JP, Palmer, CR, Pearson, G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. Journal of Infection 1998; 36: 189–196.
7.Petersson, K, et al. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstetricia et Gynecologica Scandinavica 2000; 79: 824–829.
8.Fuente, MC, Bovone, NS, Cabral, GE. Prophylaxis of prenatal toxoplasmosis [in Spanish]. Medicina (Buenos Aires) 1997; 57: 155–160.
9.Bouratbine, A, et al. Sero-epidemiologic profile of toxoplasmosis in northern Tunisia [in French]. Parasite 2001; 8: 61–66.
10.el-Nawawy, A, et al. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. Journal of Tropical Pediatrics 1996; 42: 154–157.
11.Faye, O, et al. Toxoplasmosis in Dakar. Seroepidemiologic sampling of 353 women of reproductive age [in French]. Bulletin de la Société de Pathologie Exotique 1998; 91: 249–250.
12.Guebre-Xabier, M, et al. Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia. Ethiopian Medical Journal 1993; 31: 201–208.
13.az-Suarez, O, et al. Seroepidemiology of toxoplasmosis in a Yucpa Amerindian community of Sierra de Perija, Zulia State, Venezuela [in Spanish]. Revista Médica de Chile 2003; 131: 1003–1010.
14.Blondel, B, et al. , The National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 2012.
15.Desmonts, G, Couvreur, J, Ben, Rachid MS. Toxoplasmosis, the mother and the child [in French]. Archives Françaises de Pédiatrie 1965; 22: 1183–1200.
16.National Laboratory of Health. Immunity and Toxoplasma infection in pregnant women in France [in French]. Bulletin Epidémiologique Hebdomadaire 1984; 51: 2–3.
17.Ancelle, T, et al. Toxoplasmosis among pregnant women in France in 1995 [in French]. Bulletin Epidémiologique Hebdomadaire 1995; 51: 227–229.
18.Berger, F, et al. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Revue d'Epidémiologie et de Santé Publique 2009; 57: 241–248.
19.Montoya, JG, Liesenfeld, O. Toxoplasmosis. Lancet 2004; 363: 1965–1976.
20.Dunn, D, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829–1833.
21.Wallon, M, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clinical Infectious Diseases 2013; 56: 1223–1231.
22.Journal Officiel de la République Française. Decree 92-143 on mandatory premarital, prenatal and postnatal examinations, 14 February 1992.
23.French National Authority for Health. Serological surveillance and prevention of toxoplasmosis and rubella during pregnancy. Public Health recommendations of the French National Authority for Health, 2009.
24.Thiebaut, R, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 2007; 369: 115–122.
25.Moncada, PA, Montoya, JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Review of Anti-infective Therapy 2012; 10: 815–828.
26.Papoz, L, et al. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. American Journal of Epidemiology 1986; 123: 154–161.
27.Ades, AE, Nokes, DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. American Journal of Epidemiology 1993; 137: 1022–1034.
29.King, L, et al. Congenital toxoplasmosis: implementation of a surveillance system in France. Bulletin Epidémiologique Hebdomadaire 2008; 14–15: 122–124.
30.Villena, I, et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Eurosurveillance 2010; 15.
32.R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2011.
34.Baril, L, et al. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scandinavian Journal of Infectious Diseases 1999; 31: 305–309.
35.Halos, L, et al. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. International Journal for Parasitology 2010; 40: 193–200.
36.Department of Statistics and Forecasting. Agreste syntheses – consumption. French Ministry of Agriculture, Food, Fisheries, Rural Affairs and Spatial Planning. French Republic. 2010.
37.Ades, AE. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiology and Infection 1992; 108: 367–375.
38.Armstrong, GL, Bell, BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109: 839–845.
39.Armstrong, GL, et al. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. Pediatrics 2001; 108: 1123–1128.
40.Cutts, FT, Vynnycky, E. Modelling the incidence of congenital rubella syndrome in developing countries. International Journal of Epidemiology 1999; 28: 1176–1184.
41.Colugnati, FA, et al. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infectious Diseases 2007; 7: 71.
42.Farrington, CP. Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953–967.